FDA approves Novo Nordisk's higher-dose Wegovy injection for weight loss
Tweet Send to a Friend
The U.S. Food and Drug Administration approved Novo Nordisk's (NYSE: NVO) Wegovy HD injection, a 7.2 mg dose of semaglutide ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
